RLMD - Relmada Therapeutics Inc. (RLMD) Q1 2024 Earnings Call Transcript
2024-05-10 07:13:10 ET
Relmada Therapeutics, Inc. (RLMD)
Q1 2024 Earnings Conference Call
May 08, 2024, 04:30 PM ET
Company Participants
Tim McCarthy - IR, LifeSci Advisors
Sergio Traversa - Chief Executive Officer
Maged Shenouda - Chief Financial Officer
Andrew Cutler - Senior Clinical Development Advisor
Conference Call Participants
Basma Radwan - Leerink Partners
Andrea Tan - Goldman Sachs
Andrew Tsai - Jefferies
Presentation
Operator
Good afternoon, ladies and gentlemen, and welcome to the Relmada Therapeutics Inc. First Quarter 2024 Financial Results Conference Call. At this time, all lines are in a listen-only mode. Following the presentation, we will conduct a question-and-answer session. [Operator Instructions] This call is being recorded on Wednesday, May 8, 2024.
I would now like to turn the conference over to Tim McCarthy, LifeSci Advisors . Please go ahead.
Tim McCarthy
Thank you, Colin and thank you all for joining us this afternoon. With me on today's call are Chief Executive Officer, Sergio Traversa and Chief Financial Officer, Maged Shenouda. This afternoon, Relmada issued a press release, providing a business update, announcing financial results for the three months ended March 31, 2024....
Relmada Therapeutics, Inc. (RLMD) Q1 2024 Earnings Call Transcript